Metraipolis › archive › dc_038848bb59e6
Primary, Secondary and Exploratory Endpoints in Phase 2 and 3 Clinical Trials with Novel Therapies in MASH Cirrhosis: A Systematic Review — Europe PMC PMID:41976922
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41976922
- DOI
- 10.3390/jcm15072621
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T17:12:36.373Z
- SHA-256 of the archived text
a6e6882e6505641b09e37388f5147f327192575441d79a1867531fed2bc188cd- Stable URL of this page
https://metraipolis.com/documento/dc_038848bb59e6
How to cite
Primary, Secondary and Exploratory Endpoints in Phase 2 and 3 Clinical Trials with Novel Therapies in MASH Cirrhosis: A Systematic Review — Europe PMC PMID:41976922 — Europe PMC (en), https://europepmc.org/article/MED/41976922 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_038848bb59e6 (Metraipolis archive dc_038848bb59e6, sha256 a6e6882e6505641b09e37388f5147f327192575441d79a1867531fed2bc188cd)
BibTeX
@misc{dc038848bb59e6,
title = {Primary, Secondary and Exploratory Endpoints in Phase 2 and 3 Clinical Trials with Novel Therapies in MASH Cirrhosis: A Systematic Review — Europe PMC PMID:41976922},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41976922},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_038848bb59e6; sha256 a6e6882e6505641b09e37388f5147f327192575441d79a1867531fed2bc188cd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41976922. Agents can read the archived copy with the MCP tool read_document.